Filter
25
Filtered Results: 25
Text search:
Drugs
for
Neglected
Diseases
initiative
DNDi
-
Latin
America
Featured
Recommendations
1
New Publications
1
Language
Document type
Studies & Reports
14
Guidelines
3
Strategic & Response Plan
3
Fact sheets
2
Manuals
1
Resource Platforms
1
No document type
1
Countries / Regions
Global
5
Latin America and the Carribbean
5
Colombia
2
North America
1
Brazil
1
Authors & Publishers
Publication Years
Category
Studies & Reports
3
Chagas
2
Leishmaniasis
2
Hepatitis
1
COVID-19
1
Guidelines
1
NTDs & Others
1
Parasitology
1
HIV & STI
1
Disease Prevention & Control
1
Pharmacy & Technologies
1
Toolboxes
Studies & Reports
5
Studies & Reports
4
Strategies & Roadmaps
3
Capacity Building & Resources
2
Information & Education Material (IEC)
2
Clinical Aspects, Treatment & Prevention
1
Country specific documents
1
Chagas
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Studies & Reports
1
Overview, Studies & Reports
1
Antiretroviral Treatment ART
1
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
In 2007, the Sixtieth World Health Assembly adopted resolution WHA60.13 on control of leishmaniasis, urging Member States, among other actions:
to strengthen prevention, active detection and treatment of cases of both cutaneous and visceral leishmaniasis in order to decrease the disease burde...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-ended list of some 20 parasitic, bact...
